GB9700664D0 - Anti-cancer agents - Google Patents

Anti-cancer agents

Info

Publication number
GB9700664D0
GB9700664D0 GBGB9700664.7A GB9700664A GB9700664D0 GB 9700664 D0 GB9700664 D0 GB 9700664D0 GB 9700664 A GB9700664 A GB 9700664A GB 9700664 D0 GB9700664 D0 GB 9700664D0
Authority
GB
United Kingdom
Prior art keywords
cancer agents
cancer
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9700664.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Technology Group Ltd filed Critical British Technology Group Ltd
Priority to GBGB9700664.7A priority Critical patent/GB9700664D0/en
Publication of GB9700664D0 publication Critical patent/GB9700664D0/en
Priority to ZA9800306A priority patent/ZA98306B/en
Priority to AU55690/98A priority patent/AU5569098A/en
Priority to PCT/GB1998/000111 priority patent/WO1998030550A1/en
Priority to CA002275566A priority patent/CA2275566A1/en
Priority to EP98900602A priority patent/EP0961772A1/en
Priority to JP53067698A priority patent/JP2001509149A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB9700664.7A 1997-01-14 1997-01-14 Anti-cancer agents Pending GB9700664D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB9700664.7A GB9700664D0 (en) 1997-01-14 1997-01-14 Anti-cancer agents
ZA9800306A ZA98306B (en) 1997-01-14 1998-01-14 Anti-cancer agents.
AU55690/98A AU5569098A (en) 1997-01-14 1998-01-14 2,4-diaminopyrimidine compounds as anti-cancer agents
PCT/GB1998/000111 WO1998030550A1 (en) 1997-01-14 1998-01-14 2,4-diaminopyrimidine compounds as anti-cancer agents
CA002275566A CA2275566A1 (en) 1997-01-14 1998-01-14 2,4-diaminopyrimidine compounds as anti-cancer agents
EP98900602A EP0961772A1 (en) 1997-01-14 1998-01-14 2,4-diaminopyrimidine compounds as anti-cancer agents
JP53067698A JP2001509149A (en) 1997-01-14 1998-01-14 2,4-diaminopyrimidine compounds as anticancer agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9700664.7A GB9700664D0 (en) 1997-01-14 1997-01-14 Anti-cancer agents

Publications (1)

Publication Number Publication Date
GB9700664D0 true GB9700664D0 (en) 1997-03-05

Family

ID=10805951

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9700664.7A Pending GB9700664D0 (en) 1997-01-14 1997-01-14 Anti-cancer agents

Country Status (7)

Country Link
EP (1) EP0961772A1 (en)
JP (1) JP2001509149A (en)
AU (1) AU5569098A (en)
CA (1) CA2275566A1 (en)
GB (1) GB9700664D0 (en)
WO (1) WO1998030550A1 (en)
ZA (1) ZA98306B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005026148A1 (en) * 2003-09-08 2005-03-24 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
ATE432077T1 (en) 2003-09-24 2009-06-15 Wyeth Corp 5-ARYLPYRIMIDINE AS AN ANTI-CANCER AGENT
TW200637556A (en) * 2005-01-31 2006-11-01 Basf Ag Substituted 5-phenyl pyrimidines I in therapy
WO2008024974A1 (en) * 2006-08-24 2008-02-28 Serenex, Inc. Pyrimidine and pyrazine derivatives
TW201016704A (en) * 2008-09-26 2010-05-01 Takeda Pharmaceutical Prevention and treatment of cancer with RAS gene mutation
US10420761B2 (en) * 2013-03-15 2019-09-24 University Of Florida Research Foundation, Inc. Allosteric inhibitors of thymidylate synthase
WO2016209688A1 (en) 2015-06-24 2016-12-29 University Of Florida Research Foundation, Incorporated Compositions for the treatment of cancer and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8314643D0 (en) * 1983-05-26 1983-06-29 Wellcome Found Pyrimidine derivatives
DE3786256T2 (en) * 1986-12-02 1993-10-07 British Tech Group ANTIFOLATE AGENT.
GB9214994D0 (en) * 1992-07-15 1992-08-26 Shea Dennis M O Pyrimidine compounds

Also Published As

Publication number Publication date
ZA98306B (en) 1999-07-14
CA2275566A1 (en) 1998-07-16
EP0961772A1 (en) 1999-12-08
JP2001509149A (en) 2001-07-10
WO1998030550A1 (en) 1998-07-16
AU5569098A (en) 1998-08-03

Similar Documents

Publication Publication Date Title
DE59803915D1 (en) Bandwaage
DE59806556D1 (en) Fmcw-sensor
DE59805100D1 (en) Containerbrücke
DE59803341D1 (en) Handhobelmaschine
DE59808840D1 (en) Compoundpumpe
DE69727985D1 (en) Extravasationserkennungsvorrichtung
DE59803148D1 (en) Dimensionsstabile thermoplastische formmassen
DE59811907D1 (en) Transponder-system
GB9700664D0 (en) Anti-cancer agents
DE69729893D1 (en) Druckbläter
DE59708342D1 (en) Basophilen-degranulationstest
EP0998924A4 (en) Antitumor agents
DE59806884D1 (en) Dexamethason-gel
DE69807904D1 (en) Augendruckmessgerät
IL136525A0 (en) Agents
DE69735266D1 (en) Substituierte naphthopyrane
GB9706063D0 (en) Contrast agents
GB9709088D0 (en) Contrast agents
CA82748S (en) Handleset
CA82746S (en) Handleset
CA82745S (en) Handleset
CA82333S (en) Remorque
DE59809032D1 (en) Telephonsystem
DE59811113D1 (en) Laryngoskop
CA82218S (en) Sports-glasses